KLAS Contact
Contact KLAS
Contact KLAS
2023 BEST IN KLAS
Preferences
Related Series
2021
2019
Related Segments
Related Articles
Drug Diversion Monitoring 2022
What Outcomes Are Provider Organizations Achieving?
Author
Jackson Tate
Author
Jennifer Hickenlooper
Current Time Inside Cache Tag Helper: 6/4/2023 7:06:47 AM and Model.reportId = 1930
Drug diversion monitoring continues to be a top area of interest for pharmacy departments across the US as they seek to understand which products can effectively identify non-compliant behavior and otherwise unknown diverters. This report—KLAS’ first to analyze the performance of several vendors in this area—looks at which vendors are consistently delivering guidance, analytics, and insights that help organizations identify and prevent drug diversion. In addition, this report examines the outcomes provider organizations are achieving and how well vendors follow through on commitments.if you don't have a login, getting started is easy.
Key Findings:
- Kit Check Customers Say High Ease of Use Facilitates Outcomes
- Protenus’ Proactive Diversion Insights Guide Customer Investigations
- Despite Mixed Experience with BD’s Guidance & Support, Customers Feel Optimistic about the Future
- Customer Satisfaction with Imprivata (Limited Data) Has Significantly Declined
Writer
Sarah Hanson
Designer
Jessica Bonnett
Project Manager
Mary Bentley
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.